Vaccines
14 October 2014
Shantha`s Investigational Rotavirus Vaccine Enters Phase III Clinical Trials in India9 October 2014
Regen BioPharma Inc. Files IND Application With FDA for dCellVax Breast Cancer Immune Therapy29 September 2014
Transgene Presents Additional Positive Clinical Data from Phase 2b Part of TIME Trial with TG4010 at ESMO24 September 2014
Inovio Pharmaceuticals Ebola Vaccine Moving into Human Trial with GeneOne Life Science23 September 2014
Novavax’ H7N9 Avian Influenza VLP Vaccine Candidate With Matrix-M(TM) Delivers Positive Phase 1/2 Clinical Data22 September 2014
Dynavax Completes Enrollment of Phase 3 Study of HEPLISAV-B18 September 2014
Boehringer Ingelheim and CureVac announce collaboration to develop next generation lung cancer immunotherapy18 September 2014
First volunteer receives new Ebola vaccine in UK trial17 September 2014
Novavax Initiates Phase 2 Clinical Trial of RSV F-Protein Nanoparticle Vaccine Candidate in Healthy Third-Trimester Pregnant Women16 September 2014
TapImmune Releases Positive Interim Data on Phase I Clinical Trial of Folate Receptor Alpha Antigens in Ovarian and Breast Cancer16 September 2014
New Data Supporting VBI’s Prophylactic Cytomegalovirus (CMV) Vaccine Candidate (VBI-1501A) Presented at the 54th ICAAC Conference in Washington, D.C.12 September 2014
Merck KGaA Discontinues Clinical Development Program of Tecemotide as a Monotherapy in Stage III Non-Small Cell Lung Cancer12 September 2014
Genocea Commences Phase 2a Trial for GEN-004, Universal Pneumococcal Vaccine Candidate8 September 2014
Novavax Presents Data on RSV F Nanoparticle Vaccine Induced Monoclonal Antibody at ICAAC4 September 2014
FDA Gives NewLink Genetics Approval to Proceed to Phase 1 Clinical Studies of Their Ebola Vaccine4 September 2014
Bavarian Nordic Accelerates Ebola Vaccine Development Programs in Collaboration with the U.S. National Institutes of Health3 September 2014
Sanofi Pasteur’s Dengue Vaccine Candidate Successfully Completes Final Landmark Phase III Clinical Efficacy Study in Latin AmericaNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports